Last week Dirk wrote about the
DSCSA Product Identifier on Drug Packages in the United States. Last month he wrote about shipping container/transport package identification under the Brazil
National Medicine Control System (SNCM) (see “
ANVISA And The SSCC Controversy”). In this article Dirk takes a look at drug package identifiers under the SNCM as regulated by the
National Agency of Sanitary Surveillance (ANVISA). Dirk is a member of the GS1 Healthcare group -
Contact GS1 Healthcare for more information.
An excerpt from Dirk's article:
"Under the SNCM, manufacturers must apply a Unique Medicine Identifier (IUM) to all drug packages imported or sold into the Brazilian supply chain and trace them through the supply chain by December 11, 2016. By December 11 of 2015, manufacturers must apply the IUM to the packages of at least three lots of drugs and trace them to the dispensing points. And you thought compliance with the DSCSA was going to be hard to achieve!
